계명대학교 의학도서관 Repository

Clinical significance of serum galactose-deficient immunoglobulin A1 for detection of recurrent immunoglobulin A nephropathy in kidney transplant recipients

Metadata Downloads
Author(s)
Woo Yeong ParkYaerim KimJin Hyuk PaekKyubok JinSeungyeup Han
Keimyung Author(s)
Park, Woo YoungKim, Yae RimPaek, Jin HyukJin, Kyu BokHan, Seung Yeup
Department
Dept. of Internal Medicine (내과학)
Journal Title
Kidney Res Clin Pract
Issued Date
2021
Volume
40
Issue
2
Keyword
GlomerulonephritisGraft survivalImmunoglobulin AKidney transplantationSurvival
Abstract
Background:
Recurrent glomerulonephritis (GN) is a common cause of allograft loss in kidney transplantation (KT), the most frequent of which is immunoglobulin A (IgA) nephropathy (IgAN). Galactose-deficient IgA1 (Gd-IgA1) plays a major role in the pathophysiology of IgAN, but the association between Gd-IgA1 and recurrent IgAN in kidney transplant recipients (KTRs) is uncertain. We aimed to evaluate the efficacy of Gd-IgA1 for prediction of recurrent IgAN and graft and patient survival according to Gd-IgA1 level.

Methods:
We enrolled 27 KTRs who underwent allograft biopsy between 2009 and 2016 and measured the serum Gd-IgA1 level of each KTR. We divided the patients into two groups: nonrecurrent IgAN (patients with IgAN prior to KT who were not diagnosed with recurrent IgAN) and recurrent IgAN (patients with IgAN prior to KT who were diagnosed with recurrent IgAN).

Results:
The mean serum Gd-IgA1 level was significantly higher in the recurrent IgAN group than in the nonrecurrent IgAN group (6,419 ± 3,675 ng/mL vs. 3,381 ± 2,844 ng/mL, p = 0.02). The cutoff value of serum Gd-IgA1 in receiver operating characteristic curve analysis was 4,338 ng/mL (area under the curve, 0.76; 95% confidence interval [CI], 0.57-0.95, p = 0.02). Serum Gd-IgA1 level was an independent factor for recurrent IgAN (odds ratio, 17.60; 95% CI, 1.33-233.03, p = 0.03). There was no significant difference in graft or patient survival between the two groups.

Conclusion:
Serum Gd-IgA1 can be used as a diagnostic biomarker for recurrent IgAN in KT.
Keimyung Author(s)(Kor)
박우영
김예림
백진혁
진규복
한승엽
Publisher
School of Medicine (의과대학)
Citation
Woo Yeong Park et al. (2021). Clinical significance of serum galactose-deficient immunoglobulin A1 for detection of recurrent immunoglobulin A nephropathy in kidney transplant recipients. Kidney Res Clin Pract, 40(2), 317–324. doi: 10.23876/j.krcp.20.183
Type
Article
ISSN
2211-9140
Source
https://www.krcp-ksn.org/journal/view.php?number=6035
DOI
10.23876/j.krcp.20.183
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/43683
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
공개 및 라이선스
  • 공개 구분공개
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.